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ABSTRACT
Objective: To examine influences of adiposity from
early adolescence to early 20s on cardiovascular
disease (CVD) risk in the multiethnic Determinants of
young Adult Social well-being and Health (DASH)
longitudinal study.
Methods: In 2002–2003, 6643 11–13-year-olds from
51 London schools participated at baseline, and 4785
were seen again at 14–16 years. Recently, 665 (97% of
invited) participated in pilot follow-up at 21–23 years,
with biological and psychosocial measures and blood
biomarkers (only at 21–23 years). Regression models
examined interplay between ethnicity, adiposity and
CVD.
Results: At 21–23 years, ∼30–40% were overweight.
About half of the sample had completed a degree with
little ethnic variation despite more socioeconomic
disadvantage in adolescence among ethnic minorities.
Regardless of ethnicity, overweight increased more
steeply between 14–16 years and 21–23 years than
between 11–13 years and 14–16 years. More
overweight among Black Caribbean and Black African
females, lower systolic blood pressure (sBP) among
Indian females and Pakistani/Bangladeshi males
compared with White UK peers, persisted from 11–
13 years. At 21–23 years, glycated haemoglobin
(HbA1c) was higher among Black Caribbean females,
total cholesterol higher and high-density lipoprotein
(HDL) cholesterol lower among Pakistani/Bangladeshis.
Overweight was associated with a ∼+2 mm Hg rise in
sBP between 11–13 years and 21–23 years. Adiposity
measures at 11–13 years were related to allostatic load
(a cluster of several risk markers), HbA1c and HDL
cholesterol at 21–23 years. Ethnic patterns in CVD
biomarkers remained after adjustments.
Conclusions: Adolescent adiposity posed significant
risks at 21–23 years, a period in the lifespan generally
ignored in cardiovascular studies, when ethnic/gender
variations in CVD are already apparent.
INTRODUCTION
The UK has a rapidly growing ethnically
diverse population. In the 2011 Census, the
non-White British population in the UK was
20% of the population and 55% in London.
The public health implications are signiﬁcant
given the well-documented ethnic disparities
in cardiometabolic disease. People of South
Asian or Black African descent have, respect-
ively, fourfold and threefold elevated risks of
diabetes compared with White Europeans.1 2
Risks of hypertension and stroke are also
greater in these groups, but while South
Asians also experience higher rates of coron-
ary disease, people of Black African origin
are protected. There is increasing evidence
that ethnic differences in risk factors such as
blood pressure (BP) emerge in childhood
with greater metabolic sensitivity to adiposity
than Whites3 including from infancy to
3-year-old.4–6 Black African and Black
Caribbean girls are more likely to be over-
weight, and Indian girls to have larger waists
(adjusted for height) in childhood compared
with their White UK counterparts. Ethnic dif-
ferences in cardiovascular (CV) health also
persist after adjustment for measures for
Strengths and limitations of this study
▪ Determinants of young Adult Social well-being
and Health (DASH) is one of the few cohorts
with an ethnically diverse composition in their
20s, a time when physical health is at its peak,
yet when early signs of disease begin to appear.
▪ DASH has high retention rates and provides a
comprehensive picture of the ethnic patterning of
growth from early adolescence.
▪ It is the first UK study, as yet from a pilot
follow-up, to report a prospective association
between adiposity measures and cardiovascular
disease risk from early adolescence to early
adulthood in an ethnically diverse cohort.
▪ The lack of data before age 11 years, blood bio-
markers only at 21–23 years and pilot sample
size at 21–23 years are limitations.
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socioeconomic circumstances (SEC). However, consider-
able debate continues as to whether the association is
causal, particularly as most studies are cross-sectional.
Obesity, and its metabolic and haemodynamic conse-
quences, underpins a signiﬁcant proportion of adult ill
health. The Foresight Obesity project forecasted that by
2050, 60% of men and 50% of women will be obese, with
growing ethnic disparities projected. The impact of
obesity acquired during rapid somatic growth on cardio-
metabolic disease is unclear, and the tracking of obesity
from adolescence into early adulthood may account
better for ethnic differences in disease. In the pilot
follow-up of our Determinants of young Adult Social well-
being and Health (DASH) study, we used an initial panel
of biomarkers, traditional and novel, neither often mea-
sured at this age. Lipid proﬁles and glycosylated haemo-
globin (HbA1c by which type 2 diabetes can now be
deﬁned) were included. Inﬂammation in adipose tissue
is likely to play a key role in vascular damage preceding
overt diabetes.7 8 Allostatic load (AL), a cluster of several
risk markers, is proposed as a biological link accounting
for Black–White/socioeconomic disparities in morbidity
and mortality in the USA, representing the cumulative
dysregulation of biological systems. It is patterned by
social determinants (eg, ethnicity, education) and pro-
spectively predicts mortality as well as cognitive and phys-
ical decline.9 10 Studies of ethnic differences in AL are
mainly US-based, where Black–White disparity emerges
by 35 years, 5 years earlier than for the UK Black
Caribbeans.11 We recently showed that by age 30 years,
most ethnic minority groups had higher AL than their
general population peers, and that living in deprived
neighbourhoods was associated with greater biological
wear and tear, independent of individual SEC.11
There are few cohorts with an ethnically diverse com-
position in early adulthood, a time when physical health
is at its peak, yet when early signs of disease begin to
appear. Studies that tracked growth from childhood and
collected biomarkers and vascular measures are mainly
of White Europeans with few in Europe varying in
ethnic make-up.12 13 The DASH study, established in
2002, has followed health and social exposures of over
6000 young Londoners (UK), including 80% ethnic
minorities, over the last 12 years. A pilot follow-up study
of the cohort, now in their early 20s, was recently com-
pleted. Here, we examine pilot-study phenotypes for
potential ethnic patterns from early adolescence to early
20s in (1) body size and BP trajectories; (2) the inﬂu-
ence of body size on BP and on vascular biomarkers
(HbA1c, total (TC) and high-density lipoprotein (HDL)
cholesterol and AL) and (3) whether gender and SEC
inﬂuenced ethnic variations in risks.
MATERIALS AND METHODS
Details of the DASH study can be found elsewhere.14 In
2002–2003, a total of 6643 students, aged 11–13 years,
from 51 secondary schools in 10 London boroughs, took
part at baseline. In 2005–2006, 4785 (88% of children in
49 schools, 72% of the initial cohort) participated in the
ﬁrst follow-up aged 14–16 years. A 10% subsample
(N=665, 97% participation rate) took part in the pilot
follow-up completed in March 2014. The subsample con-
sisted of 107 White UK, 102 Black Caribbean, 132 Black
African, 99 Indian, 111 Bangladeshi or Pakistani and
115 other (mainly mixed) ethnicities. We ﬁrst tried to
locate the sample and 81% (5414 of 6643) of the cohort
was traced through friendship networks, social media,
and community campaigns. We then randomly selected
100 (50 per gender) in each in ethnic group, and prag-
matically attempted, by repeated random selection, to
ensure representation across the London boroughs,
schools and SEC at 11–13 years.
Written informed consent was obtained from all parti-
cipants. Ethnicity was self-reported, checked against
reported parental ethnicity and grandparents’ country
of birth. Bangladeshis and Pakistanis were combined
due to small sample sizes.
Body size, biological and social measures
Field staff were trained for 1 week prior to the start of
ﬁeldwork, and were recertiﬁed at 6-monthly intervals.
Equipment was calibrated regularly by the ﬁeld supervi-
sors. During adolescence, assessments were conducted
in schools and at 21–23 years, in community locations
(eg, local general practitioner’s surgeries, local commu-
nity pharmacies, King’s College London).
Body Mass Index (BMI) can underestimate body fat
among South Asians and overestimate among African-
origin populations.15 In the absence of bioelectrical
impedance at all ages, we used waist to height ratio
(WHtR) and overweight/obesity status (referred to as
overweight hereafter). Height was measured using port-
able stadiometers, to the nearest 0.1 cm and weight using
Salter electronic scales, to the nearest 0.1 kg. In adoles-
cence, participants were classiﬁed as normal weight, over-
weight or obese using the International Obesity Task
Force, based on the 1990 British growth reference
curves.16 At 21–23 years, overweight was classiﬁed as a
BMI of 25–29.9 kg/m2, obese a BMI of ≥30 kg/m2. Waist
circumference (cm) was measured midway between the
10th rib and the top of the iliac crest, and 0.5 cm sub-
tracted to correct for measurement over T-shirt or vest.
The mean of two duplicate measures was derived for the
WHtR.
BP was measured using validated OMRON M5–1
instruments and appropriately sized cuffs, after sitting
quietly for a timed 5 min, with >1 min between three
subsequent readings. The mean of the second and third
readings was used in analysis. A 25 mL blood sample was
taken by venepuncture at 21–23 years. We examined the
following seven biomarkers: systolic blood pressure
(sBP), diastolic blood pressure (dBP), WHtR, BMI, TC,
HDL cholesterol and HbA1c. These biomarkers were
used to create AL, based on the highest risk quartile
values of the sample distribution.17 A biomarker reading
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beyond the threshold (<25th centile for HDL choles-
terol, >75th centile for all other biomarkers) was
assigned one point, corresponding to thresholds of: sBP
121/dBP 77 mm Hg; BMI 26.8 kg/m2; WHtR male 0.89,
female 0.86; TC 4.8 mmol/L; HDL cholesterol
1.8 mmol/L; HbA1c 37.0 mmol/mol. AL score was
derived by summing the points.
A self-complete questionnaire measured smoking, SEC
(as family afﬂuence and parental employment in adoles-
cence, own education and employment at 21–23 years).
Statistical analysis
Continuous variables (sBP, dBP, WHtR, BMI, TC, HDL
cholesterol and HbA1c) did not require transformation
as the Shapiro-Wilk test indicated normal distributions.
All models were gender-stratiﬁed. We ﬁrst examined
potential effects of age (used as single years) and ethni-
city, adjusted for each other, on outcomes.
Ethnic-speciﬁc effects were tested using interaction
terms ethnicity × age and ethnicity × adiposity. Measures
of adiposity (WHtR, overweight) were added to the core
model with age and ethnicity, using separate models for
each adiposity measure. Models were gender-stratiﬁed.
Social correlates (SEC, smoking) were added to the
models only if they were statistically signiﬁcant in uni-
variable analyses and where the log likelihood ratios
indicated better ﬁtted models.
Mixed-effects models examined longitudinal outcomes
for sBP and adiposity measures (WHtR—linear models,
overweight/obese vs normal weight—logistic models).
Linear regression models were used for HbA1c, HDL,
TC and AL. Two sets of models were run. The ﬁrst set
was with adiposity measures at 11–13 years to examine
whether, at this critical period of adolescence, there was
an association with biomarkers at 21–23 years. The
second investigated the inﬂuence of change in adiposity
measures between 11–13 years and 21–23 years. Stata
V.13 was used for all analyses. Missing data among con-
tinuous variables were <5% for BP and anthropometric
variables (N=664 for mixed-effects models with BP as
outcome) and 24% for blood biomarkers (N=502 for
linear regression models). Missing data for categorical
covariates were coded and included in the analyses.
Statistical signiﬁcance was considered at p<0.05.
RESULTS
Table 1 shows distributions by social correlates, ethnicity
and age. Ethnic minorities were generally less likely to
smoke, Black Africans least. Completion of a degree did
not vary signiﬁcantly, despite more socioeconomic disad-
vantage in adolescence among the ethnic minority
groups.
Ethnic patterns in body size and BP trajectories from early
adolescence to early 20s
Figure 1 and online supplementary table S1 show CV
markers by ethnicity and gender.
At 11–13 years, Black Caribbeans and Black Africans
were 2–3 cm taller, Indians ∼5 cm shorter and
Pakistanis/Bangladeshis ∼2 cm shorter than White UK.
At 14–16 and 21–23 years, however, the White UK–
ethnic minority difference was evident only for South
Asians, who remained shorter (see online
supplementary table S1).
Figure 1 and online supplementary table S1 show that
from adolescence there was a pattern of more over-
weight/obesity for Black Caribbeans and Black Africans
than their White UK peers. In every ethnic group, for
males and females, there was a marked increase in
WHtR between 14–16 years and 21–23 years, signiﬁcantly
more for Pakistanis/Bangladeshis than for White UK.
sBP rose more in males than females. While sBP rose
more in adolescence between 14–16 years and 21–
23 years for Black Caribbean and Black African males,
the opposite was observed for White UK.
At 21–23 years, compared with their White UK peers,
mean HbA1c was higher among Black Caribbean
females, mean TC higher among Pakistani/Bangladeshi
males and mean HDL cholesterol lower among Indian
and Pakistani/Bangladeshi males (see online
supplementary table S1).
The influence of body size on BP and biomarkers
Table 2 shows the inﬂuence of longitudinal measures of
WHtR and overweight from 11–13 years to 21–23 years
on sBP by gender. These indices were independent lon-
gitudinal correlates of sBP (and dBP—see online
supplementary table S2). For example, between 11–
13 years and 21–23 years overweight among females was
associated with an average rise of +2.89 mm Hg (1.43–
4.34) in sBP, and +3.09 (1.70–4.48) for dBP (see online
supplementary table S2) compared with normal weight.
The addition of SEC or smoking did not substantively
change the results in the models for BP. Despite more
overweight among females than males from adoles-
cence, in gender-adjusted models, mean sBP was lower
(−7.95 mm Hg, 95% CI −9.10 to −6.79). In these
models with additional adjustments, the pattern of gen-
erally lower sBP for many ethnic minority groups was
observed before and after adjustment for the different
adiposity indices.
Tables 3 (males) and 4 (females) show the inﬂuence
of WHtR and overweight status at 11–13 years on per
unit change in vascular biomarkers at 21–23 years, by
gender. Adiposity at 11–13 years was related to three
(AL, HbA1c, HDL cholesterol) of four biomarkers. The
corresponding results for change in adiposity are in
online supplementary table S3 and online
supplementary table S4. Increasing WHtR was associated
with a decrease in HDL cholesterol and an increase in
TC, and overweight at 11–13 years and 21–23 years with
a decrease in HDL cholesterol (see online
supplementary table S3). The unadjusted ethnic and
gender patterns largely remained after adjustment for
adiposity. In all of these models, there were no
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Table 1 Descriptive profile of longitudinal pilot follow-up sample: percentage (95% CI) by ethnicity
White UK
(N=107)
Black African
(N=132)
Black Caribbean
(N=102) Indian (N=98)
Pakistani
Bangladeshi
(N=111) Others (N=115) All (N=665)
Socioeconomic circumstances at 11–13 years
Parental unemployment
≥1 employed 89.7 (82.3 to 94.2) 76.5 (68.5 to 83.0) 77.4 (68.3 to 84.6) 75.6 (66.0 to 83.1) 57.7 (48.2 to 66.5) 80.0 (71.6 to 86.4) 76.1 (72.7 to 79.2)
None employed 5.6 (2.5 to 12.0) 15.1 (10.0 to 22.4) 15.7 (9.8 to 24.1) 12.2 (7.1 to 20.4) 30.6 (22.7 to 39.9) 13.9 (8.7 to 21.6) 15.6 (13.1 to 18.6)
Not stated 4.7 (1.9 to 10.8) 8.3 (4.7 to 14.4) 6.9 (3.3 to 13.8) 12.2 (7.1 to 20.4) 11.7 (6.9 to 19.2) 6.1 (2.9 to 12.3) 8.3 (6.4 to 10.6)
Family Affluence Scale*
≥3 60.7 (51.1 to 69.6) 47.7 (39.3 to 56.3) 50.0 (40.3 to 59.6) 50.0 (40.2 to 59.8) 43.2 (34.3 to 52.6) 60.0 (50.7 to 68.6) 51.9 (48.1 to 55.7)
1–2 29.0 (21.1 to 38.3) 27.3 (20.3 to 35.5) 32.4 (23.9 to 42.1) 30.6 (22.2 to 40.5) 36.0 (27.6 to 45.4) 27.8 (20.4 to 36.7) 30.4 (27.0 to 34.0)
0 1.0 (1.2 to 6.4) 1.5 (0.4 to 5.9) 7.8 (3.9 to 15.0) 2.0 (0.5 to 78.9) 3.6 (1.3 to 9.3) 1.7 (0.4 to 6.7) 2.8 (1.8 to 4.4)
Not stated 9.3 (5.1 to 16.6) 23.5 (17.0 to 31.5) 9.8 (5.3 to 17.3) 10.4 (6.0 to 17.5) 17.2 (11.2 to 25.3) 10.4 (6.0 to 17.5) 14.9 (12.4 to 17.8)
Socioeconomic circumstances at 14–16 years
Parental unemployment
≥1 employed 86.0 (78.0 to 91.4) 81.8 (74.2 to 87.5) 79.4 (70.4 to 86.2) 84.7 (76.1 to 90.6) 57.7 (48.2 to 66.5) 35.7 (27.4 to 44.8) 70.5 (67.0 to 73.9)
None employed 0.9 (0.1 to 6.4) 12.1 (7.5 to 18.9) 13.7 (8.3 to 21.9) 7.1 (3.4 to 14.3) 30.6 (22.7 to 39.9) 4.3 (1.8 to 10.1) 11.6 (9.3 to 14.2)
Not stated 13.1 (7.9 to 20.9) 6.1 (3.0 to 11.7) 6.9 (3.3 to 13.8) 8.2 (4.1 to 15.5) 11.7 (6.9 to 19.2) 60.0 (50.7 to 68.6) 17.9 (15.1 to 21.0)
Family Affluence Scale*
≥3 60.7 (51.1 to 70.0) 47.7 (39.3 to 56.3) 50.0 (40.3 to 59.6) 50.0 (40.2 to 59.8) 43.2 (34.3 to 52.6) 60.0 (50.7 to 68.6) 61.6 (57.9 to 65.3)
1–2 29.0 (21.1 to 38.3) 27.3 (20.3 to 35.5) 32.3 (23.9 to 42.1) 30.6 (22.2 to 40.5) 36.0 (27.6 to 45.4) 27.8 (20.4 to 36.7) 27.5 (24.2 to 31.0)
0 1.0 (0.1 to 6.4) 1.5 (0.4 to 5.9) 7.8 (3.9 to 15.0) 2.1 (0.5 to 7.9) 3.6 (1.3 to 9.3) 1.7 (0.4 to 6.7) 1.7 (0.9 to 3.0)
Not stated 9.3 (5.1 to 15.6) 23.5 (17.0 to 31.5) 9.8 (5.3 to 17.3) 17.3 (11.0 to 26.2) 17.2 (11.2 to 25.3) 10.4 (6.0 to 17.5) 9.2 (7.2 to 11.6)
Socioeconomic circumstances at 21–23 years
Own employment
Yes 49.5 (40.1 to 59.0) 45.5 (37.1 to 54.0) 53.9 (44.1 to 63.4) 48.0 (38.2 to 57.9) 39.7 (30.9 to 40.1) 48.7 (39.6 to 57.8) 47.4 (42.6 to 51.2)
No 42.1 (33.0 to 51.6) 37.1 (29.3 to 45.7) 33.3 (24.8 to 43.1) 37.7 (28.7 to 47.8) 42.3 (33.5 to 51.7) 37.8 (29.0 to 46.6) 38.3 (34.7 to 42.1)
Not stated 8.4 (4.4 to 15.4) 17.4 (11.8 to 24.9) 12.8 (7.5 to 20.8) 14.3 (8.6 to 22.8) 18.0 (11.9 to 26.3) 13.9 (8.7 to 2.6) 14.3 (11.8 to 17.2)
Education
Not educated to
a degree level
51.4 (41.9 to 60.8) 33.3 (25.8 to 41.8) 58.8 (49.0 to 68.0) 32.6 (24.1 to 42.6) 38.7 (30.1 to 48.1) 46.1 (37.1 to 55.3) 43.2 (39.4 to 47.0)
Educated to a
degree level
40.2 (31.3 to 49.8) 57.6 (49.0 to 65.8) 34.3 (25.7 to 44.1) 57.1 (47.1 to 66.6) 48.6 (39.4 to 57.9) 43.5 (34.7 to 52.7) 47.2 (43.4 to 51.0)
Not stated 8.4 (4.4 to 15.4) 9.1 (5.2 to 15.4) 6.9 (3.3 to 13.8) 10.2 (5.5 to 18.0) 12.6 (7.6 to 20.2) 10.4 (6.0 to 17.5) 9.6 (7.6 to 12.1)
Smoking
11–13 years 2.8 (0.9 to 8.4) 0 4.9 (2.0 to 11.3) 0 0.9 (0.1 to 6.2) 0.9 (1.2 to 6.2) 1.5 (0.8 to 2.8)
Not stated 8.4 (4.4 to 15.4) 29.5 (22.3 to 37.9) 15.7 (9.8 to 24.1) 17.3 (11.0 to 26.2) 18.0 (11.9 to 26.3) 19.1 (12.9 to 27.4) 18.5 (15.7 to 21.6)
14–16 year 15.9 (10.1 to 24.1) 8.8 (4.6 to 16.1) 2.3 (0.7 to 6.8) 3.1 (1.0 to 9.1) 2.7 (0.1 to 8.1) 12.2 (7.3 to 19.6) 7.4 (5.6 to 9.6)
Not stated 5.6 (2.5 to 12.0) 4.9 (2.0 to 11.3) 6.8 (3.6 to 12.6) 7.1 (3.4 to 14.3) 6.3 (3.0 to 12.7) 10.4 (6.0 to 17.5) 6.9 (5.2 to 9.1)
21–23 years 46.7 (37.4 to 56.2) 10.6 (6.4 to 17.1) 20.6 (13.8 to 29.6) 23.5 (16.1 to 32.9) 24.3 (17.2 to 33.2) 23.5 (16.6 to 32.1) 24.4 (21.2 to 27.8)
Not stated 21.5 (14.7 to 30.3) 53.0 (44.5 to 61.4) 41.2 (32.0 to 51.0) 46.9 (37.2 to 56.9) 47.7 (38.6 to 57.1) 38.3 (29.8 to 47.5) 41.8 (38.1 to 45.6)
*Family affluence was derived from the number of cars or vans, computers and holidays abroad each year.
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discernible ethnic-speciﬁc effects as tested by the interac-
tions ethnicity × age, and ethnicity × adiposity measure.
DISCUSSION
This is the ﬁrst UK study, as yet from a pilot follow-up,
to report a prospective association between adiposity
measures and cardiovascular disease (CVD) risk from
early adolescence to early adulthood in an ethnically
diverse cohort. At 11–13 years, 30% of the follow-up
sample was overweight/obese compared with 39% at
21–23 years, with a larger increase between 14–16 years
and 21–23 years than between 11–13 years and
14–16 years. There was a striking steady increase in
smoking from early adolescence. Ethnic patterns in BP
and vascular biomarkers varied by gender, and were
unaltered after adjustment for adiposity or social
factors. Of note was that from early adolescence, Black
Caribbeans and Black Africans were more likely to be
overweight than their White UK peers, with Black
Caribbean females also having a higher HbA1c at
21–23 years. Regardless of ethnicity, adiposity measures
were related to sBP at each age, and adiposity measures
at 11–13 years were related to the AL, HbA1c and HDL
at 21–23 years.
Growth acceleration for ethnic minorities from a
young age may have had some impact. The Millennium
Cohort Study showed accelerated growth from birth for
ethnic minority children who were not preterm or small
for dates.18 Black Caribbean babies were about 150 g
lighter than their White British peers but by age 3 years
they were about 1 kg heavier and 2 cm taller. Indian
Figure 1 Waist to height ratio, per cent of overweight/obese and systolic blood pressure by age and ethnicity for males and
females: means/percentage and 95% CIs adjusted for gender and ethnicity. BA, Black African; BC, Black Caribbean; PB,
Pakistani/Bangladeshi.
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babies were about 290 g lighter at birth, showed a
similar trend of growth acceleration such that by 5 years
they were of similar weight and height. At ages
<11 years, cross-sectional studies have shown that Black
African-origin children are ∼3 cm taller and heavier and
South Asians ∼2 cm shorter and lighter than Whites in
Britain.3 19 In DASH, the taller heights of the Black
Caribbean and Black Africans at 11–13 years but not at
14–16 years5 or 21–23 years support accelerated growth
patterning prior to 11–13 years. South Asians remained
shorter at 21–23 years than White UK, a pattern consist-
ent with other studies of young children.19 The larger
body size for Black Caribbeans and Black Africans also
correspond with other studies.18 20
Childhood growth acceleration is associated with later
obesity and CVD, via mechanisms including rises in BP,
types of fat deposition as well as perhaps insulin resist-
ance. Differential growth and metabolic factors between
birth and 3 years of age between South Asians and
Europeans suggest insulin levels change after those of
adiposity, as also shown by adiponectin concentrations.4
That remains our hypothesis,21 not least because ‘insulin
resistance’ fails to predict coronary heart disease
(CHD), its excess or other vascular events in South
Asians,22 or in other insulin resistance syndromes.23
Growth acceleration in infancy may be a critical
period,24 as may be the ‘adiposity rebound’, thought to
be around ages 5–8 years but often earlier in poorer,
Table 2 Systolic blood pressure from adolescence to early adulthood for males and females: association with longitudinal
measures of adiposity*
Waist to height ratio Overweight status
Coef 95% CI p Value Coef 95% CI p Value
Males
Waist to height ratio 25.94 13.72 to 38.16 <0.001 – – –
Overweight (normal weight—Ref)
Overweight/obese – – – 1.60 −0.25 to 3.46 0.091
Age (11–13 years—Ref) (years)
14–16 6.73 5.39 to 8.08 <0.001 6.62 5.28 to 7.96 <0.001
21–23 8.98 7.52 to 10.44 <0.001 10.57 9.15 to 12.0 <0.001
Ethnicity (White UK—Ref)
Black Caribbean −1.08 −4.30 to 2.14 0.512 −1.44 −4.73 to 1.85 0.39
Black African −0.97 −4.03 to 2.09 0.532 −1.25 −4.38 to 1.88 0.434
Indian −3.16 −6.30 to −0.02 0.048 −3.14 −6.34 to 0.06 0.055
Pakistani/Bangladeshi −5.58 −8.60 to −2.56 <0.001 −5.32 −8.41 to −2.23 0.001
Others −4.26 −7.38 to −1.14 <0.001 −4.26 −7.45 to −1.07 0.009
Employment
No 0.43 −1.17 to 2.04 0.6 0.27 −13.1 to 1.85 0.741
Not stated 1.24 −1.04 to 3.54 0.286 0.72 −1.53 to 2.97 0.533
Smoking
Yes 0.89 −0.64 to 2.42 0.253 0.92 −0.60 to 2.44 0.238
Not stated 2.58 0.82 to 4.33 0.004 2.73 0.99 to 4.46 0.002
Females
Waist to height ratio 30.18 20.98 to 39.37 <0.001 – – –
Overweight (normal weight—Ref)
Overweight/obese – – – 2.89 1.43 to 4.34 <0.001
Age (11–13 years—Ref) (years)
14–16 −0.94 −2.05 to 16.81 0.096 −0.52 −1.63 to 0.60 0.569
21–23 −1.66 −2.93 to −0.39 0.082 1.17 −0.04 to 2.38 0.058
Ethnicity (White UK—Ref)
Black Caribbean −0.38 −2.82 to 2.06 0.758 0.06 −2.42 to 2.54 0.961
Black African 0.24 −2.06 to 2.55 0.836 0.45 −1.88 to 2.79 0.703
Indian −2.63 −5.19 to −0.06 0.045 −2.19 −4.79 to 0.41 0.099
Pakistani/Bangladeshi −2.31 −4.83 to 0.20 0.071 −1.93 −4.5 to 0.63 0.139
Others −0.84 −3.29 to 1.61 0.502 −0.72 −3.22 to 1.77 0.569
Employment
No −0.39 −1.64 to 0.86 0.543 −0.40 −1.65 to 0.65 0.527
Not stated 1.59 −0.64 to 3.82 0.162 1.41 −0.77 to 3.59 0.204
Smoking
Yes 0.54 −0.76 to 1.85 0.418 0.66 −0.64 to 1.97 0.317
Not stated 0.46 −0.91 to 1.84 0.508 0.22 −1.14 to 1.59 0.755
*Mixed-effects linear regression model for systolic blood pressure: regression coefficients adjusted for age, ethnicity, waist to height ratio or
overweight (separate models), parental/own employment and currently smoking.
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Table 3 Males: the influence of adiposity at 11–13 years on biomarkers at 21–23 years*
Allostatic load HbA1c
Waist to height ratio Overweight status Waist to height ratio Overweight status
Coef 95% CI p Value Coef 95% CI p Value Coef 95% CI p Value Coef 95% CI p Value
Waist to height ratio, 11–13 years 7.69 4.27 to 11.11 <0.001 – – – 3.31 −5.33 to 11.92 0.450 – – –
Overweight, 11–13 years (normal weight—Ref)
Overweight/obese – – – 0.87 0.44 to 1.31 <0.001 – – – 1.06 −0.03 to 2.15 0.057
Ethnicity (White UK—Ref)
Black Caribbean −0.07 −0.77 to 0.63 0.843 −0.32 −1.02 to 0.38 0.365 0.93 −0.84 to 2.70 0.301 0.61 −1.14 to 2.35 0.493
Black African −0.38 −1.06 to 0.30 0.272 −0.74 −1.42 to −0.06 0.033 1.04 −0.66 to 2.74 0.228 0.81 −0.87 to 2.50 0.344
Indian −0.26 −0.92 to 0.41 0.449 −0.30 −0.97 to 0.37 0.383 1.35 −0.31 to 3.03 0.111 1.35 −0.32 to 3.02 0.113
Pakistani/Bangladeshi −0.07 −0.72 to 0.59 0.835 −0.11 −0.77 to 0.55 0.751 0.71 −0.90 to 2.33 0.383 0.58 −1.02 to 2.18 0.478
Others −0.35 −0.99 to 0.30 0.289 −0.50 −1.15 to 0.15 0.133 0.10 −1.53 to 1.71 0.848 −0.07 −1.70 to 1.55 0.929
HDL cholesterol Total cholesterol
Waist to height ratio Overweight status Waist to height ratio Overweight status
Coef 95% CI p Value Coef 95% CI p Value Coef 95% CI p Value Coef 95% CI p Value
Waist to height ratio, 11–13 years 0.2 −0.5 to 0.23 0.568 – – – 0.96 −0.82 to 2.73 0.289 – – –
Overweight, 11–13 years (normal weight—Ref)
Overweight/obese – – – −0.03 −0.12 to 0.06 0.529 – – – −0.01 −0.23 to 0.22 0.968
Ethnicity (White UK—Ref)
Black Caribbean 0.09 −0.05 to 0.23 0.207 0.10 −0.04 to 0.24 0.165 −0.02 −0.38 to 0.34 0.914 −0.05 −0.40 to 0.31 0.788
Black African 0.06 −0.13 to 0.14 0.932 0.01 −0.13 to 0.14 0.965 −0.24 −0.59 to 0.11 0.179 −0.27 −0.61 to 0.08 0.132
Indian −0.13 −0.27 to 0.02 0.054 −0.15 −0.29 to −0.01 0.03 0.09 −0.26 to 0.43 0.609 0.10 −0.24 to 0.45 0.548
Pakistani/Bangladeshi −0.16 −0.29 to −0.03 0.018 −0.18 −0.30 to −0.04 0.01 0.35 −0.02 to 0.68 0.040 0.35 0.02 to 0.68 0.036
Others 0.02 −0.11 to 0.16 0.568 0.02 −0.12 to 0.16 0.74 0.03 −0.30 to 0.36 0.860 0.02 −0.31 to 0.36 0.883
*Linear regression model with regression coefficients adjusted for ethnicity and waist to height ratio or overweight status at 11–13 years. Allostatic load score derived at 21–23 years using
high-risk thresholds defined as below the 25th centile for high-density lipoprotein (HDL) cholesterol, and above the 75th centile for all other biomarkers. The thresholds were: systolic,
121.0 mm Hg; diastolic, 77 mm Hg; BMI, 26.8 kg/m2; waist to height ratio male, 0.89, and female, 0.86; total cholesterol, 4.8 mmol/L; HDL cholesterol, 1.8 mmol/L; glycated haemoglobin
(HbA1c), 37.0 mmol/mol.
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Table 4 Females: the influence of adiposity at 11–13 years on biomarkers at 21–23 years in the DASH study*
Covariates
Allostatic load HbA1c
Waist to height ratio Overweight status Waist to height ratio Overweight status
Coef 95% CI p Value Coef 95% CI p Value Coef 95% CI p Value Coef 95% CI p Value
Waist to height ratio, 11–13 years 11.36 7.76 to 17.95 <0.001 – – – 22.12 8.65 to 33.59 0.007 – – –
Overweight, 11–13 years (normal weight—Ref)
Overweight/obese – – – 1.23 0.80 to 1.67 <0.001 – – – 1.68 0.16 to 3.18 0.029
Ethnicity (White UK—Ref)
Black Caribbean 0.22 −0.42 to 0.85 0.5 0.04 −0.61 to 0.69 0.903 2.65 0.32 to 4.98 0.026 2.51 0.16 to 4.86 0.037
Black African −0.11 −0.75 to 0.52 0.723 −0.25 −0.89 to 0.39 0.439 0.4 −1.84 to 2.64 0.725 0.39 −1.87 to 2.66 0.732
Indian −0.2 −0.88 to 0.48 0.56 −0.06 −0.74 to 0.63 0.871 −0.04 −2.54 to 2.46 0.973 0.19 −2.29 to 2.67 0.881
Pakistani/Bangladeshi −0.5 −1.15 to 0.15 0.134 −0.49 −1.15 to 0.17 0.145 −0.2 −2.60 to 2.20 0.869 −0.15 −2.57 to 2.27 0.834
Others −0.48 −1.10 to 0.15 0.134 −0.52 −1.15 to 0.11 0.108 0.52 −1.78 to 2.81 0.656 0.63 −1.67 to 2.92 0.592
HDL cholesterol Total cholesterol
Waist to height ratio Overweight status Waist to height ratio Overweight status
Coef 95% CI p Value Coef 95% CI p Value Coef 95% CI p Value Coef 95% CI p Value
Waist to height ratio, 11–13 years −0.94 −1.87 to −0.02 0.045 – – – 0.73 −1.16 to 2.62 0.449 – – –
Overweight, 11–13 years (normal weight—Ref)
Overweight/obese – – – −0.13 −0.23 to −0.02 0.017 – – – −0.01 −0.32 to 0.38 0.906
Ethnicity (White UK—Ref)
Black Caribbean −0.01 −0.17 to 0.26 0.975 0.03 −0.13 to 0.20 0.699 0.05 −0.31 to 0.40 0.793 0.03 −0.34 to 0.36 0.965
Black African 0.05 −0.11 to 0.21 0.537 0.07 −0.08 to 0.23 0.335 −0.28 −0.62 to 0.05 0.095 −0.28 −0.62 to 0.05 0.1
Indian −0.11 −0.29 to 0.06 0.207 −0.13 −0.30 to 0.04 0.142 −0.05 −0.43 to 0.32 0.787 −0.06 −0.43 to 0.31 0.752
Pakistani/Bangladeshi 0.04 −0.13 to 0.22 0.617 0.02 −0.15 to 0.19 0.857 0.05 −0.31 to 0.42 0.771 0.06 −0.30 to 0.42 0.746
Others −0.03 −0.20 to 0.13 0.698 −0.05 −0.21 to 0.11 0.561 −0.06 −0.40 to 0.28 0.734 −0.05 −0.39 to 0.29 0.767
*Linear regression model with regression coefficients adjusted for ethnicity and waist to height ratio or overweight status at 11–13 years. Allostatic load score derived at 21–23 years using
high-risk thresholds defined as below the 25th centile for high-density lipoprotein (HDL) cholesterol, and above the 75th centile for all other biomarkers. The thresholds were: systolic,
121.0 mm Hg; diastolic, 77 mm Hg; BMI, 26.8 kg/m2; waist to height ratio male, 0.89, and female, 0.86; total cholesterol, 4.8 mmol/L; HDL cholesterol, 1.8 mmol/L; glycated haemoglobin
(HbA1c), 37.0 mmol/mol.
DASH, Determinants of young Adult Social well-being and Health.
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marginally or undernourished communities.25 Early
studies in marginally nourished settings in Jamaica
showed at ages 0–5 year that height and weight lagged
25% centile points behind Boston, USA, standards of
the time.26 That study is probably representative of
parents and their children who would be the grandpar-
ents and parents who migrated to Britain as the fore-
bears of the Caribbean-origin sample here. Similarly,
early child cohorts show the impact on child growth and
early mortality, mostly from malaria, in West Africa. Over
50 years ago, infants, universally breast fed, gained
weight and height similarly to the UK children for the
ﬁrst 6 months, then when weaned, growth faltered,
although in the Gambian setting without overt malnutri-
tion.27 Recent studies in Nigeria, with parasitaemia
examined throughout pregnancy, suggest that birth
dimensions were lower and infant BP by age 1 year had
climbed faster, even adjusting for catch-up growth.28
Postnatal child growth is also affected by other inherent
(eg, haemoglobin genotype) exposure to obesogenic
neighbourhoods (eg, high density of fast food outlets),29
earlier maturation and mixed feeding as infants.
The ethnic-speciﬁc blood biomarker proﬁles suggest
changing lipid proﬁles among Black Caribbeans. Earlier
studies of adult migrant Caribbeans,2 30 and those in the
Caribbean,31 32 showed lipid proﬁles that were protective
of CHD—lower total, low-density lipoprotein (LDL)
cholesterol and triglyceride concentrations and higher
HDL cholesterol. Fasting bloods were not taken in
DASH but total and HDL cholesterol, unaffected by
fasting, were not different from White UK. This is con-
sistent with previous reports of lipid proﬁles among 9–
10 year-old33 and 35–44 year-old UK-born Black
Caribbeans. The lower HDL cholesterol among South
Asian males indicates some continuity of patterns for
these groups. Contrary to what could be expected from
the US-based studies and our own of 35–54-year-olds,34
ethnic differences in AL were not evident in early 20s.
This raises questions about what might be mitigating bio-
logical ‘wear and tear’ in the context of disproportionate
exposure to socioeconomic disadvantage and obesity
from a younger age. Physical activity in the 20s (as mea-
sured by accelerometry) may have a protective effect.35
DASH contains a diverse sample, has high retention
rates and low item-non-response, mainly due to enor-
mous community support. The lack of data before age
11 years, and blood biomarkers only at 21–23 years, lack
of body composition measures at age 11 years, and the
small sample sizes for the ethnic groups in the pilot
follow-up are limitations. Prior to DASH, a large-scale
study with an explicit focus on ethnicity had not been
attempted. Our pilot studies in 2001 suggested that
response rates would be low if bloods were taken and
starting at younger ages would incur a high loss to
follow-up between primary and secondary schools.
Measuring adiposity in ethnic minorities is not unprob-
lematic but whether ethnic-speciﬁc bioelectrical imped-
ance analysis calibration is required continues to be
debated.15 19 At 21–23 years, fat mass and lean mass
were measured using Bodystat 1500MDD. The ethnic
patterns in fat mass corresponded to those reported
here using anthropometric measures. For example,
among females the fat mass indices (kg/m2) were as
follows—White UK 6.41 (95% CI 5.50 to 7.32), Black
Caribbeans 9.13 (95% CI 7.80 to 10.46), Black Africans
8.01 (95% CI 7.02 to 9.00), Indians 7.71 (95% CI 6.67 to
8.74) and Pakistanis/Bangladeshis 7.43 (95% CI 6.43 to
8.42). The small sample size of the ethnic groups pro-
hibited robust testing of ethnic-speciﬁc effects. The
primary aims of the pilot follow-up were to locate the
diverse groups in the cohort, investigate whether they
would participate in a subsequent follow-up study and
agree for their parents to be invited to join DASH, and
whether they would consent to the different measures,
notably the biomarkers. Missing data were low for
anthropometry and BP but relatively high for the blood
biomarkers which could have introduced bias. Despite
these small numbers, these ﬁndings in a small age range
provide a robust platform for planning future studies.
A recent stabilisation of obesity rates in children in
England is good news but there is no room for compla-
cency. Early adolescent overweight adversely affected CV
health of 20-year-olds and overweight increased between
late teens and early 20s, regardless of gender or ethnicity.
Physical peak is expected in the 20s, a transitional age that
is ignored in interventions. Urgent attention is required to
prevent diminishing ‘peak’ health in a ‘coming of age’
generation that faces the additional challenges from eco-
nomic precarity due to the economic recession.
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